The value of MRD as a marker for disease eradication in AML VJHemOnc – Video Journal of Hematology & HemOnc 1:23 9 months ago 90 Далее Скачать
Advances and unanswered questions in AML: novel agents, MRD assessment, and immunotherapy VJHemOnc – Video Journal of Hematology & HemOnc 3:22 3 months ago 131 Далее Скачать
The value of moving novel agents into the frontline setting in ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:50 1 year ago 104 Далее Скачать
Hyper-CVAD with NEL and PEG in T-ALL/LBL VJHemOnc – Video Journal of Hematology & HemOnc 2:14 3 years ago 455 Далее Скачать
Safety & efficacy of nelarabine, pegylated asparaginase and venetoclax in frontline therapy of T-ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:10 2 years ago 259 Далее Скачать
Anti-CD47 antibodies for complex karyotype AML VJHemOnc – Video Journal of Hematology & HemOnc 0:47 1 year ago 77 Далее Скачать
The addition of venetoclax to hyper-CVAD-nelarabine and pegylated asparagine in T-ALL VJHemOnc – Video Journal of Hematology & HemOnc 2:19 2 months ago 77 Далее Скачать
Safety and tolerability of AMG 330, a bispecific T-cell engager, in adult patients with R/R AML VJHemOnc – Video Journal of Hematology & HemOnc 1:20 5 months ago 69 Далее Скачать
The search for better post-MPN AML treatment: decitabine and ruxolitinib VJHemOnc – Video Journal of Hematology & HemOnc 1:38 4 years ago 45 Далее Скачать
Oral combination of ASTX727 (decitabine/cedazuridine) plus Ven for older/unfit patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 2:23 1 year ago 90 Далее Скачать
Ponatinib + venetoclax for the treatment of R/R Ph+ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:02 2 years ago 158 Далее Скачать
The challenges of treating AML in older patients VJHemOnc – Video Journal of Hematology & HemOnc 2:12 5 years ago 106 Далее Скачать
MRD status vs treatment intensity in predicting the outcome of patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 2:18 1 year ago 53 Далее Скачать
Nelarabine, PEG-asparaginase and venetoclax added to HCVAD in T-ALL/T-LBL VJHemOnc – Video Journal of Hematology & HemOnc 1:43 1 year ago 190 Далее Скачать
Breakthroughs in the treatment of elderly patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 1:57 6 years ago 102 Далее Скачать
Current management of Ph-positive ALL VJHemOnc – Video Journal of Hematology & HemOnc 1:52 6 years ago 548 Далее Скачать
MRD negativity predicts improved survival in AML VJHemOnc – Video Journal of Hematology & HemOnc 2:53 3 years ago 294 Далее Скачать
The importance of MRD monitoring in patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 1:06 1 year ago 84 Далее Скачать
Oral combination of HMAs + venetoclax in unfit or elderly patients with AML VJHemOnc – Video Journal of Hematology & HemOnc 1:40 2 years ago 229 Далее Скачать
QUAZAR AML-001: oral azacitidine as maintenance therapy in AML VJHemOnc – Video Journal of Hematology & HemOnc 6:03 4 years ago 384 Далее Скачать
